BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Packer M. Role of ketogenic starvation sensors in mediating the renal protective effects of SGLT2 inhibitors in type 2 diabetes. J Diabetes Complications 2020;34:107647. [PMID: 32534886 DOI: 10.1016/j.jdiacomp.2020.107647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yaribeygi H, Maleki M, Nasimi F, Butler AE, Jamialahmadi T, Sahebkar A. Sodium-glucose co-transporter 2 inhibitors and hematopoiesis. J Cell Physiol 2022. [PMID: 35951776 DOI: 10.1002/jcp.30851] [Reference Citation Analysis]
2 Yan H, Wen Y, Liu B. Renoprotective mechanisms of SGLT2 inhibitor in diabetic kidney disease. Diabetic Nephropathy 2022;0. [DOI: 10.2478/dine-2022-0009] [Reference Citation Analysis]
3 Li X, Flynn ER, do Carmo JM, Wang Z, da Silva AA, Mouton AJ, Omoto ACM, Hall ME, Hall JE. Direct Cardiac Actions of Sodium-Glucose Cotransporter 2 Inhibition Improve Mitochondrial Function and Attenuate Oxidative Stress in Pressure Overload-Induced Heart Failure. Front Cardiovasc Med 2022;9:859253. [DOI: 10.3389/fcvm.2022.859253] [Reference Citation Analysis]
4 Ala M, Khoshdel MRF, Dehpour AR, Sturza A. Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats. Oxidative Medicine and Cellular Longevity 2022;2022:1-9. [DOI: 10.1155/2022/1197061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Zhou X, Zhang Y, Wang N. Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease. Front Physiol 2021;12:764503. [PMID: 34675822 DOI: 10.3389/fphys.2021.764503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ekanayake P, Mudaliar S. A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitors. Diabetes Obes Metab 2022;24:3-11. [PMID: 34605129 DOI: 10.1111/dom.14562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ogura Y, Kitada M, Koya D. Sirtuins and Renal Oxidative Stress. Antioxidants (Basel) 2021;10:1198. [PMID: 34439446 DOI: 10.3390/antiox10081198] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Yoneda M, Honda Y, Ogawa Y, Kessoku T, Kobayashi T, Imajo K, Ozaki A, Nogami A, Taguri M, Yamanaka T, Kirikoshi H, Iwasaki T, Kurihashi T, Saito S, Nakajima A. Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial.BMJ Open Diabetes Res Care. 2021;9. [PMID: 33593749 DOI: 10.1136/bmjdrc-2020-001990] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
9 Leoncini G, Russo E, Bussalino E, Barnini C, Viazzi F, Pontremoli R. SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits. Int J Mol Sci 2021;22:4441. [PMID: 33922865 DOI: 10.3390/ijms22094441] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Sen T, Heerspink HJL. A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors. Cell Metab 2021;33:732-9. [PMID: 33691091 DOI: 10.1016/j.cmet.2021.02.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
11 Salgado JV, Goes MA, Salgado Filho N. FGF21 and Chronic Kidney Disease. Metabolism 2021;118:154738. [PMID: 33617873 DOI: 10.1016/j.metabol.2021.154738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Abduraman MA, Azizan NA, Teoh SH, Tan ML. Ketogenesis and SIRT1 as a tool in managing obesity. Obes Res Clin Pract 2021;15:10-8. [PMID: 33371997 DOI: 10.1016/j.orcp.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]